Cytokine knockouts in contact hypersensitivity research

Cytokine and Growth Factor Reviews

Volumn 14, Issue 5, 2003, Pages 381-389

  Wang, Binghe ^a   Esche, Clemens ^a   Mamelak, Adam ^a   Freed, Irwin ^a   Watanabe, Hideaki ^a   Sauder, Daniel N ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chemokine; Contact hypersensitivity; Cytokine; Knockout mice; Langerhans cell

Indexed keywords

ANTIGEN; CYTOKINE; CYTOKINE RECEPTOR;

ANTIGEN PRESENTATION; CELL MIGRATION; CELLULAR IMMUNITY; CONTACT ALLERGY; CYTOKINE PRODUCTION; EPIDERMIS; GENE TARGETING; HYPERSENSITIVITY; IMMUNE RESPONSE; KNOCKOUT MOUSE; LANGERHANS CELL; LYMPH NODE; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; T LYMPHOCYTE;

EID: 0041874894     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(03)00050-9     Document Type: Short Survey

References (76)

1. + type 1 cytotoxic T cells both play a crucial role in the full development of contact hypersensitivity. J Immunol 2000;165:6783-90.
2. Grabbe S, Schwarz T. Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol Today 1998;19:37-44.
3. Gorbachev AV, Fairchild RL. Induction and regulation of T-cell priming for contact hypersensitivity. Crit Rev Immunol 2001;21:451-72.
4. Girolomoni G, Sebastiani S, Albanesi C, Cavani A. T-cell sub-populations in the development of atopic and contact allergy. Curr Opin Immunol 2001;13:733-7.
5. Girardi M, Lewis J, Glusac E, et al. Resident skin-specific γδ T cells provide local, nonredundant regulation of cutaneous inflammation. J Exp Med 2002;195:855-67.
6. Wang B, Amerio P, Sauder DN. Role of cytokines in Langerhans cell migration. J Leukoc Biol 1999;66:33-9.
7. Maurer D, Stingl G. Langerhans cells. In: Lotze MT, Thomson AW. editors. Dendritic cells. 2nd ed. San Diego: Academic Press; 2001. p. 35-50.
8. Mak TW, Penninger JM, Ohashi PS. Knockout mice: a paradigm shift in modern immunology. Nat Rev Immunol 2001;1:11-9.
9. Wang B, Feliciani C, Freed I, Cai Q, Sauder DN. Insights into molecular mechanisms of contact hypersensitivity gained from gene knockout studies. J Leukoc Biol 2001;70:185-91.
10. Enk AH, Katz SI. Early molecular events in the induction phase of contact sensitivity. Proc Natl Acad Sci USA 1992;89:398-1402.
11. Cumberbatch M, Dearman RJ, Kimber L. Langerhans cells require signals from both TNF-α and IL-1β for migration. Immunology 1997;92:388-95.
12. Luger TA, Stadler BM, Katz SI, Oppenheim JJ. Epidermal cell (keratinocyte-derived thymocyte activating factor (ETAF)). J Immunol 1981;127:1493-8.
13. Sauder DN, Carter CS, Katz SI, Oppenheim JJ. Epidermal cell production of thymocyte activating factor (ETAF). J Invest Dermatol 1982;79:34-9.
14. Dunn E, Sims JE, Nicklin MJH, O'Neill LAJ. Annotating genes with potential roles in the immune system: six new members of the IL-1 family. Trends Immunol 2001;22:533-6.
15. Enk AH, Angeloni VL, Udey MC, Katz SI. An essential role for Langerhans cell-derived ILβ-1 in the initiation of primary immune responses in skin. J Immunol 1993;150:3698-704.
16. Cunberbatch M, Dearman RJ, Antonopoulos C, Groves RW, Kimber I. Interleukin (IL)-18 induces Langerhans cell migration by a tumour necrosis factor-α and IL-1β-dependent mechanism. Immunology 2001;102:323-30.
17. Wang B, Felciani C, Howell BG, et al. Contribution of Langerhans cell-derived IL-18 to contact hypersensitivity. J Immunol 2000;168:3303-8.
18. Cumberbatch M, Kimber I. Tumor necrosis factor-α is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization. Immunology 1995;84:31-5.
19. Jakob T, Udey MC. Regulation of E-cadherin-mediated aclhesion adhesion in Langerhans-like dendritic cells by inflammatory mediators that mobilize Langerhans cells in vivo. J Immunol 1998;160:4067-73.
20. Piguet PF, Grau GE, Hauser C, Vassalli P. Tumor necrosis factor is a critical mediator in hapten induced irritant and contact hypersensitivity reactions. J Exp Med 1991;173:673-9.
21. Kondo S, Pastore S, Fujisawa H, et al. Interleukin-1 receptor antagonist suppresses contact hypersensitivity. J Invest Dermatol 1995;105:334-8.
22. Nakae S, Naruse-Nakajima C, Sudo K, Horai R, Asano M, Iwakura Y. IL-1α, but not IL-1β, is required for contact-allergen-specific T cell activation during the sensitization phase in contact hypersensitivity. Int Immunol 2001;13:1471-8.
23. Shornick LP, De Togni P, Mariathasan S, et al. Mice deficient in IL-1β manifest impaired contact hypersensitivity to trinitrochlorobenzene. J Exp Med 1996;183:1427-36.
24. Zheng H, Fletcher D, Kozak W, et al. Resistance to fever induction and impaired acute-phase response in interleukin-1β-deficient mice. Immunity 1995;3:9-19.
25. Groves R, Antonopoulos C, Cumberbatch M, et al. Interleukin-18 is a key mediator of epidermal Langerhans cell migration and contact hypersensitivity in mice. J Invest Dermatol 2002:308.
26. Hope JC, Campbell F, Hopkins SJ. Deficiency of IL-2 or IL-6 reduces lymphocyte proliferation, but only IL-6 deficiency decreases the contact hypersensitivity response. Eur J Immunol 2000;30:197-203.
27. Pasparakis M, Alexopoulou L, Episkopou V, Kollias G. Immune and inflammatory responses in TNFα-deficient mice: a critical requirement for TNFα in the formation of primary B cell follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J Exp Med 1996;184:1397-441.
28. Kondo S, Wang B, Fujisawa H, et al. Effect of gene-targeted mutation in TNF receptor (p55) on contact hypersensitivity and ultraviolet B-induced immunosuppression. J Immunol 1995;155:3801-5.
29. Wang B, Fujisawa H, Zhuang L, et al. Depressed Langerhans cell migration and reduced contact hypersensitivity response in mice lacking TNF receptor p75. J Immunol 1997;159:6148-55.
30. Amerio P, Toto P, Feliciani C, et al. Rethinking the role of tumour necrosis factor-α in ultraviolet (UV) B-induced immunosuppression: altered immune response in UV-irradiated TNFR1R2 gene-targeted mutant mice. Br J Dermatol 2001;144:952-7.
31. Antonopoulos C, Cumberbatch M, Dearman RJ, Daniel RJ, Kimber I, Groves RW. Functional caspase-1 is required for Langerhans cell migration and optimal contact sensitization in mice. J Immunol 2001;166:3672-7.
32. Kimber I, Dearman RJ, Cumberbatch M, Huby RJ. Langerhans cells and chemical allergy. Curr Opin Immunol 1998;10:614-9.
33. Rossi DR, Zlotnik A. The biolgy of chemokines and their receptors. Annu Rev Immunol 2000;18:217-42.
34. Nelson PJ, Krensky AM. Chemokines, chemokine receptors and allografts rejection. Immunity 2001;14:377-86.
35. Sallusto F, Mackay CF, Lanzavecchia A. The role of chemokine receptors in primary, effector, and memory immune responses. Annu Rev Immunol 2000;18:593-620.
36. Moser B, Loetscher P. Lymphocyte traffic control by chemokines. Nat Immunol 2001;2:123-8.
37. Robbiani DF, Finch RA, Jager D, Muller WA, Sartorelli AC, Randolph GJ. The leukotriene C4 transporter MRP1 regulates CCL19 (MIP-3β, ELC) -dependent mobilization of dendritic cells to lymph nodes. Cell 2000;103:757-68.
38. Engeman TM, Gorbachev AV, Gladue RP, Heeger PS, Fairchaild RL. Inhibition of functional T cell priming and CHS response by treatment with anti-secondary lymphoid chemokine antibody during hapten sensitization. J Immunol 2000;164:5207-14.
39. Saeki H, Moore AM, Brown MJ, Hwang ST. Secondary lymphoid tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J Immunol 1999;162:2472-5.
40. Forster R, Schubel A, Breifeld D, et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 1999;99:23-33.
41. Zhou Y, Kurihara T, Ryseck RP, et al. Impaired macrophage function and enhanced T cell-dependent immune response in mice lacking CCR5, the mice homologue of the major HIV-1 coreceptor. J Immunol 1998;160:4018-25.
42. Varona R, Villares R, Carramolino L, et al. CCR6-deficient mice have impaired leukocyte homeostasis and hypersensitivity responses. J Clin Invest 2001;107:R37-45.
43. Sato N, Ahuja SK, Quinones M, et al. CC chemokine receptor (CCR) 2 is required for Langerhans cell migration and location of T helper cell type I (Thl)-inducing dendritic cells. Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 cytokines, B cell outgrowth, and sustained neutrophilic inflammation. J Exp Med 2000;192:205-18.
44. Landsteiner K, Jacobs J. Studies on the sensitization of animals with simple chemical compounds. II. J Exp Med 1936;64:625-39.
45. Catalina MD, Carroll MC, Arizpe H, Takashima A, Estess P, Siegelman MH. The route of antigen entry determines the requirement for L-selectin during immune responses. J Exp Med 1996;184:2341-51.
46. Pugh CW, MacPherson GG, Steer HW. Characterization of nonlymphoid cells derived from rat peripheral lymph. J Exp Med 1983;157:1758-79.
47. Rennert PD, James D, Mackay F, Browning JL, Hochman PS. Lymph node genesis is induced signaling through the lymphotoxin β receptor. Immunity 1998;9:71-9.
48. Rennert PD, Hochman PS, Flavell RA, et al. Essential role of lymph nodes in contact hypersensitivity revealed in lymphotoxin-α-deficient mice. J Exp Med 2001;193:1227-38.
49. Reeve VE, Bosnic M, Nishimura N. Interferon-γ is involved in photoimmunoprotection by UVA (320-400 nm) radiation in mice. J Invest Dermatol 1999;112:945-50.
50. Saulnier M, Huang S, Aguet M, Ryffel B. Role of interferon-γ in contact hypersensitivity assessed in interferon-γ receptor-deficient mice. Toxicology 1995;102:301-12.
51. Lu B, Ebensperger C, Dembic Z, et al. Targeted disruption of the interferon-γ receptor 2 gene results in severe immune defects in mice. Proc Natl Acad Sci USA 1998;95:8233-8.
52. Berg DJ, Leach MW, Kuhn R, et al. Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses. J Exp Med 1995;182:99-108.
53. Wang B, Zhuang L, Fujisawa H, et al. Enhanced epidermal Langerhans cell migration in IL-10 knockout mice. J Immunol 1999;162:277-83.
54. Gautam SC, Chikkala NF, Hamilton TA. Anti-inflammatory action of IL-4. J Immunol 1992;148:1411-5.
55. Asada H, Linton J, Katz SI. Cytokine gene expression during elicitation phase of contact hypersensitivity: regulation by endogenous IL-4. J Invest Dermatol 1997;108:406-11.
56. Traidl C, Jugert F, Krieg T, Merk H, Hunzelmann N. Inhibition of allergic contact dermatitis to DNFB but not to oxazolone in interleukin-4-deficient mice. J Invest Dermatol 1999;112:476-82.
57. Yokozeki H, Ghoreishi M, Takagawa K, et al. Signal transducer and activator of transcription 6 is essential in the induction of contact hypersensitivity. J Exp Med 2000;191:995-1004.
58. Infante-Duarte C, Horton HF, Byme MC, Kamradt T. Microbial lipopeptides induce the production of IL-17 in the Th cells. J Immunol 2000;165:6107-15.
59. Lebecque S, Fossiez F, Baltes E. IL-17. In: Oppenheim JJ, Feldman M, et al., editors. Cytokine reference. San Diego: Academic Press; 2000. p. 241-50.
60. Nakae S, Komiyama Y, Nambu A, et al. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 2002;17:375-87.
61. Homey B, Alenius H, Muller A, et al. CCL27-CCR10 interaction regulate T cell-mediated skin inflammation. Nat Med 2002;8:157-65.
62. Morales J, Homey B, Vicari AP, et al. CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cell. Proc Natl Acad Sci USA 1999;96:14470-5.
63. Sebastiani S, Albanesi C, De Pita O, Puddu P, Cavani A, Girolomoni G. The role of chemokines in allergic contact dermatitis. Arch Dermatol Res 2002;293:552-9.
64. Goebeler M, Trautmann A, Voss A, Brocker E-B, Toksoy A, Gillitzer R. Differential and sequential expression of multiple chemokines during elicitation of allergic contact hypersensitivity. Am J Pathol 2001;158:431-40.
65. Nakamura K, Williams IR, Kupper TS. Keratinocyte-derived monocyte chemoattractant protein 1 (MCP-1): analysis in a transgenic model demonstrate MCP-1 can recruit dendritic and Langerhans cells to skin. J Invest Dermatol 1995;105:635-43.
66. Lu B, Rutledge BJ, Gu L, et al. Abnormality in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med 1998;187:601-8.
67. Dufour JH, Dziejman M, Liu MT, Leung JH, Lane TE, Luster AD. IFN-γ-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J Immunol 2002;168:3195-204.
68. Weiss JM, Renkl AC, Maier CS, et al. Osteopontin is involved in the initiation of cutaneous contact hypersensitivity by inducing Langerhans and dendritic cell migration to lymph nodes. J Exp Med 2001;194:1219-29.
69. + T cells. J Immunol 1995;154:5071-9.
70. Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavechia A, Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of IL-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 1996;184:747-52.
71. Muller G, Saloga J, Germann T, Schuler G, Knop J, Enk AH. IL-12 as mediator and adjuvant for the induction of contact sensitivity in vivo. J Immunol 1995;155:4661-8.
72. Riemann H, Schwarz A, Grabbe S, et al. Neutralization of IL-12 in vivo prevents induction of contact hypersensitivity and induces hapten-specific tolerance. J Immunol 1996;155:1799-803.
73. Gorbachev AV, Dilulio NA, Fairchild RL. IL-12 augments CD8+ T cell development for contact hypersensitivity responses and circumvents anti-CD154 antibody-mediated inhibition. J Immunol 2001;167:156-62.
74. Mach N, Lantz CS, Galli SJ, et al. Involvement of interleukin-3 in delayed-type hypersensitivity. Blood 1998;91:778-83.
75. Gillessen S, Mach N, Small C, Mihm M, Dranoff G. Overlapping roles for granulocyte-macrophage colony-stimulating factor and interleukin-3 in eosinophil homeostasis and contact hypersensitivity. Blood 2001;97:922-8.
76. Borkowski TA, Letterio JJ, Farr AG, Udey MC. A role for endogenous transforming growth factor β 1 in Langerhans cell biology: the skin of transforming growth factor β 1 null mice is devoid of epidermal Langerhans cells. J Exp Med 1996;184:2417-22.